Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Drug-induced cholestasis (DIC) is poorly understood and its preclinical prediction is mainly limited to assessing the compound’s potential to inhibit the bile salt export pump (BSEP). Here, we evaluated two 3D spheroid models, one from primary human hepatocytes (PHH) and one from HepaRG cells, for the detection of compounds with cholestatic liability. By repeatedly co-exposing both models to a set of compounds with different mechanisms of hepatotoxicity and a non-toxic concentrated bile acid (BA) mixture for 8 days we observed a selective synergistic toxicity of compounds known to cause cholestatic or mixed cholestatic/hepatocellular toxicity and the BA mixture compared to exposure to the compounds alone, a phenomenon that was more pronounced after extending the exposure time to 14 days. In contrast, no such synergism was observed after both 8 and 14 days of exposure to the BA mixture for compounds that cause non-cholestatic hepatotoxicity. Mechanisms behind the toxicity of the cholestatic compound chlorpromazine were accurately detected in both spheroid models, including intracellular BA accumulation, inhibition of ABCB11 expression and disruption of the F-actin cytoskeleton. Furthermore, the observed synergistic toxicity of chlorpromazine and BA was associated with increased oxidative stress and modulation of death receptor signalling. Combined, our results demonstrate that the hepatic spheroid models presented here can be used to detect and study compounds with cholestatic liability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“3D spheroid models are reported to produce more accurate assessment of acute and possibly also chronic drug-induced hepatotoxicity than traditional 2D culture models (Messner et al. 2013) and to be capable of detecting compounds with cholestatic liability (Hendriks et al. 2016).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“However, a recent report suggested that bile-acid transport inhibition might be involved in part in bosentan-induced cytotoxicity in this model.”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“Addition of extracellular bile acids in the cell-culture media caused increased cytotoxicity of liver spheroid cultures relative to normal media treated spheroid cultures treated with bosentan over 14 day (Hendriks et al. 2016).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Self-citationOutcome and prognostic markers in severe drug‐induced liver disease†
Björnsson, E., & Olsson, R. (2005) · Hepatology · doi:10.1002/hep.20800 · Cited by 524
Landry, J., Bernier, D., Ouellet, C., Goyette, R., & Marceau, N. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.914 · Cited by 520
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
Alnouti, Y. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn268 · Cited by 390
Padda, M. S., Sanchez, M., Akhtar, A. J., & Boyer, J. L. (2011) · Hepatology · doi:10.1002/hep.24229 · Cited by 387
Swift*, B., Pfeifer*, N. D., & Brouwer, K. L. R. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491881 · Cited by 365
Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040758 · Cited by 343
Morgan, R. E., Trauner, M., van Staden, C. J., Lee, P. H., Ramachandran, B., Eschenberg, M., Afshari, C. A., Qualls, C. W., Lightfoot-Dunn, R., & Hamadeh, H. K. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq269 · Cited by 325
Multi-cell type human liver microtissues for hepatotoxicity testing
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0968-2 · Cited by 319
Self-citation
Cited by
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“Taken together, the findings in this report in addition to the recent published report by Hendriks et al. (2016) support that hLiMT may be a valuable in vitro tool to evaluate the functional and phenotypic (e.g., cytotoxicity) effects of bile-acid transport inhibition in an intact hepatocellular…”
BackgroundResultInfluentialSelf-citationHuman Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease
Ramli, M. N. B., Lim, Y. S., Koe, C. T., Demircioglu, D., Tng, W., Gonzales, K. A. U., Tan, C. P., Szczerbinska, I., Liang, H., Soe, E. L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.010 · Cited by 278
The evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G., Hewitt, P., Mow, T., Oinonen, T., Roth, A., Steger-Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 255
Weaver, R. J., Blomme, E. A., Chadwick, A. E., Copple, I. M., Gerets, H. H. J., Goldring, C. E., Guillouzo, A., Hewitt, P. G., Ingelman-Sundberg, M., Jensen, K. G., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0048-x · Cited by 249
Self-citationHuman hepatic 3D spheroids as a model for steatosis and insulin resistance
Kozyra, M., Johansson, I., Nordling, Å., Ullah, S., Lauschke, V. M., & Ingelman-Sundberg, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32722-6 · Cited by 173
Self-citationBioprinting of Multiscaled Hepatic Lobules within a Highly Vascularized Construct
Kang, D., Hong, G., An, S., Jang, I., Yun, W., Shim, J., & Jin, S. (2020) · Small · doi:10.1002/smll.201905505 · Cited by 164
Lauschke, V. M., Shafagh, R. Z., Hendriks, D. F. G., & Ingelman‐Sundberg, M. (2019) · Biotechnology Journal · doi:10.1002/biot.201800347 · Cited by 153
Self-citationDrug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review
Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X. (2020) · Micromachines · doi:10.3390/mi11040381 · Cited by 140
A critical perspective on 3D liver models for drug metabolism and toxicology studies
Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138
Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
Ewart, L., Dehne, E.-M., Fabre, K., Gibbs, S., Hickman, J., Hornberg, E., Ingelman-Sundberg, M., Jang, K.-J., Jones, D. R., Lauschke, V. M., et al. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052722 · Cited by 128
Self-citationKenna, J. G., Taskar, K. S., Battista, C., Bourdet, D. L., Brouwer, K. L. R., Brouwer, K. R., Dai, D., Funk, C., Hafey, M. J., Lai, Y., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1222 · Cited by 123
Liver organ-on-chip models for toxicity studies and risk assessment
Messelmani, T., Morisseau, L., Sakai, Y., Legallais, C., Goff, A. L., Leclerc, É., & Jellali, R. (2022) · Lab on a Chip · doi:10.1039/d2lc00307d · Cited by 120
Baze, A., Parmentier, C., Hendriks, D. F. G., Hurrell, T., Heyd, B., Bachellier, P., Schuster, C., Ingelman-Sundberg, M., & Richert, L. (2018) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2018.0134 · Cited by 93
Self-citationZhou, Y., Shen, J. X., & Lauschke, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01093 · Cited by 85
“In addition, spheroid assays have been presented that are tailored to identify and study specific hepatotoxicity mechanisms, such as cholestasis (Hendriks et al., 2016) and steatosis (Kozyra et al., 2018).”
BackgroundHuman Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
Hurrell, T., Kastrinou-Lampou, V., Fardellas, A., Hendriks, D. F. G., Nordling, Å., Johansson, I., Baze, A., Parmentier, C., Richert, L., & Ingelman-Sundberg, M. (2020) · Cells · doi:10.3390/cells9040964 · Cited by 82
Self-citationGholobova, D., Gérard, M., Decroix, L., Desender, L., Callewaert, N., Annaert, P., & Thorrez, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-30123-3 · Cited by 84
Sadrabadi, F., Alarcan, J., Sprenger, H., Braeuning, A., & Buhrke, T. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03649-3 · Cited by 80
Messner, S., Fredriksson, L., Lauschke, V. M., Roessger, K., Escher, C., Bober, M., Kelm, J. M., Ingelman-Sundberg, M., & Moritz, W. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2017.0022 · Cited by 72
Self-citationLi, F., Cao, L., Parikh, S., & Zuo, R. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.02.021 · Cited by 72
Deng, J., Zhang, X., Chen, Z., Luo, Y., Lu, Y., Liu, T., Wu, Z., Jin, Y., Zhao, W., & Lin, B. (2019) · Biomicrofluidics · doi:10.1063/1.5070088 · Cited by 70
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
New approach methodologies (NAMs) for human-relevant biokinetics predictions
Punt, A., Bouwmeester, H., Blaauboer, B. J., Coecke, S., Hakkert, B., Hendriks, D. F. G., Jennings, P., Kramer, N. I., Neuhoff, S., Masereeuw, R., et al. (2020) · ALTEX · doi:10.14573/altex.2003242 · Cited by 99
Flampouri, E., Imar, S., OConnell, K., & Singh, B. (2019) · ACS Sensors · doi:10.1021/acssensors.8b01490 · Cited by 63
Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59
“Another study presented spheroid models to study cholestatic liability of compounds and showed that HepaRG spheroids as well as pHH spheroids were both able to reliably predict cholestasis [62].”
BackgroundHendriks, D. F. G., Vorrink, S. U., Smutny, T., Sim, S. C., Nordling, Å., Ullah, S., Kumondai, M., Jones, B. C., Johansson, I., Andersson, T. B., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1860 · Cited by 57
Self-citationAleo, M. D., Shah, F., Allen, S. W., Barton, H. A., Costales, C., Lazzaro, S., Leung, L. Y., Nilson, A. L., Obach, R. S., Rodrigues, A. D., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00262 · Cited by 58
Mechanisms and in vitro models of drug-induced cholestasis
Gijbels, E., Vilas‐Boas, V., Deferm, N., Devisscher, L., Jaeschke, H., Annaert, P., & Vinken, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02437-2 · Cited by 62
Cox, C. R., Lynch, S., Goldring, C. E., & Sharma, P. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.611913 · Cited by 68
Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 67
An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D
Ott, L. M., Ramachandran, K., & Stehno-Bittel, L. (2017) · SLAS Discovery · doi:10.1177/2472555217701058 · Cited by 55
Lee, H., Kim, J., Choi, Y., & Cho, D. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01735 · Cited by 56
Hiemstra, S., Ramaiahgari, S. C., Wink, S., Callegaro, G., Coonen, M., Meerman, J., Jennen, D., van den Nieuwendijk, K., Dankers, A., Snoeys, J., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02552-0 · Cited by 53
Riede, J., Wollmann, B. M., Molden, E., & Ingelman‐Sundberg, M. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000340 · Cited by 58
Self-citationHan, P., Li, X., Yang, J., Zhang, Y., & Chen, J. (2024) · Environment & Health · doi:10.1021/envhealth.4c00043 · Cited by 57
Angireddy, R., Chowdhury, A. R., Zielonka, J., Ruthel, G. T., Kalyanaraman, B., & Avadhani, N. G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.030 · Cited by 60
In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach
Tabernilla, A., Rodrigues, B. D. S., Pieters, A., Caufriez, A., Leroy, K., Campenhout, R. V., Cooreman, A., Gomes, A. R., Arnesdotter, E., Gijbels, E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095038 · Cited by 61
In Vitro Models for Studying Chronic Drug-Induced Liver Injury
Donato, M. T., Ferrer, G. G., & Tolosa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911428 · Cited by 54
Shen, J. X., Youhanna, S., Zandi Shafagh, R., Kele, J., & Lauschke, V. M. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00245 · Cited by 49
Lee, H.-J., Son, M. J., Ahn, J., Oh, S. J., Lee, M., Kim, A., Jeung, Y.-J., Kim, H.-G., Won, M., Lim, J. H., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.041 · Cited by 47
Liu, Y., Gill, E., & Huang, Y. Y. S. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0084 · Cited by 51
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury
Gijbels, E., Vilas‐Boas, V., Annaert, P., Vanhaecke, T., Devisscher, L., & Vinken, M. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02691-9 · Cited by 51
Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition
Vilas‐Boas, V., Gijbels, E., Jonckheer, J., Waele, E. D., & Vinken, M. (2019) · Environment International · doi:10.1016/j.envint.2019.105422 · Cited by 47
Rose, S., Cuvellier, M., Ezan, F., Carteret, J., Bruyère, A., Legagneux, V., Nesslany, F., Baffet, G., & Langouët, S. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03178-x · Cited by 53
Multiscale modelling of drug transport and metabolism in liver spheroids
Leedale, J., Kyffin, J. A., Harding, A. L., Colley, H. E., Murdoch, C., Sharma, P., Williams, D. P., Webb, S. D., & Bearon, R. N. (2020) · Interface Focus · doi:10.1098/rsfs.2019.0041 · Cited by 52
van Berlo, D., van de Steeg, E., Amirabadi, H. E., & Masereeuw, R. (2021) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2021.05.001 · Cited by 50
Crouchet, É., Bandiera, S., Fujiwara, N., Li, S., Saghire, H. E., Fernández-Vaquero, M., Riedl, T., Sun, X., Hirschfield, H., Jühling, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25468-9 · Cited by 52
Weaver, R. J., Betts, C., Blomme, E. A. G., Gerets, H. H. J., Gjervig Jensen, K., Hewitt, P. G., Juhila, S., Labbe, G., Liguori, M. J., Mesens, N., et al. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1341489 · Cited by 42
Rowe, C., Shaeri, M., Large, E. M., Cornforth, T. V., Robinson, A., Kostrzewski, T. M., Sison-Young, R. L. C., Goldring, C. E., Park, K., & Hughes, D. J. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.09.012 · Cited by 41
Organs-on-a-chip: A new paradigm for toxicological assessment and preclinical drug development
Bovard, D., Iskandar, A., Luettich, K., Hoeng, J., & Peitsch, M. C. (2017) · Toxicology Research and Application · doi:10.1177/2397847317726351 · Cited by 35
Mizoi, K., Arakawa, H., Yano, K., Koyama, S., Kojima, H., & Ogihara, T. (2020) · Biomedicines · doi:10.3390/biomedicines8100374 · Cited by 36
Xiao, R., Lv, T., Tu, X., Li, P., Wang, T., Dong, H., Tu, P., & Ai, X. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27931 · Cited by 38
Liver-on-chips for drug discovery and development
Mehta, V., Karnam, G., & Madgula, V. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 35
Basharat, A., Rollison, H. E., Williams, D. P., & Ivanov, D. P. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115279 · Cited by 33
Primary hepatocytes and their cultures for the testing of drug-induced liver injury
Vilas‐Boas, V., Cooreman, A., Gijbels, E., Campenhout, R. V., Arnesdotter, E., Ballet, S., Annaert, P., Cogliati, B., & Vinken, M. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.08.001 · Cited by 40
Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications
Xu, Q. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.730008 · Cited by 39
3D Hepatic Organoid-Based Advancements in LIVER Tissue Engineering
Panwar, A., Das, P., & Tan, L. P. (2021) · Bioengineering · doi:10.3390/bioengineering8110185 · Cited by 36
Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
Tátrai, P., Erdő, F., & Krajcsi, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010029 · Cited by 35
Hughes, D. J., Kostrzewski, T., & Sceats, E. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217708976 · Cited by 31
Stem cell models as an in vitro model for predictive toxicology
Lynch, S., Pridgeon, C. S., Duckworth, C. A., Sharma, P., Park, B. K., & Goldring, C. E. (2019) · Biochemical Journal · doi:10.1042/bcj20170780 · Cited by 36
Ogoke, O., Maloy, M. H., & Parashurama, N. (2020) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12650 · Cited by 30
Fernández-Murga, M. L., Petrov, P., Conde, I., Castell, J. V., Gómez‐Lechón, M. J., & Jover, R. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.07.017 · Cited by 32
Penman, S. L., Sharma, P., Aerts, H., Park, B. K., Weaver, R. J., & Chadwick, A. E. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104595 · Cited by 29
Sun, S., Wang, J., Yao, J., Guo, H., & Dai, J. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151509 · Cited by 27
Advantages and Potential Benefits of Using Organoids in Nanotoxicology
Nikonorova, V. G., Chrishtop, V. V., Mironov, V. A., & Prilepskii, A. Y. (2023) · Cells · doi:10.3390/cells12040610 · Cited by 32
In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist
Vinken, M. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2201-4 · Cited by 26
Kohara, H., Bajaj, P., Yamanaka, K., Miyawaki, A., Harada, K., Miyamoto, K., Matsui, T., Okai, Y., Wagoner, M. P., & Shinozawa, T. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz229 · Cited by 26
Cuvellier, M., Rose, S., Ezan, F., Jarry, U., Oliveira, H., Bruyère, A., Rochelle, C. D. L., Legagneux, V., Langouët, S., & Baffet, G. (2022) · Biofabrication · doi:10.1088/1758-5090/ac7825 · Cited by 25
Current insights in the complexities underlying drug-induced cholestasis
Deferm, N., Vocht, T. D., Qi, B., Brantegem, P. V., Gijbels, E., Vinken, M., de Witte, P. A. M., Bouillon, T. W., & Annaert, P. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1635081 · Cited by 27
Hepatic bile acid synthesis and secretion: Comparison of in vitro methods
de Bruijn, V. M. P., Wang, Z., Bakker, W., Zheng, W., Spee, B., & Bouwmeester, H. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.06.004 · Cited by 25
Parmentier, C., Hendriks, D. F. G., Heyd, B., Bachellier, P., Ingelman‐Sundberg, M., & Richert, L. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.06.1069 · Cited by 22
Self-citationOrganotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis
Ramaiahgari, S., & Ferguson, S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_20 · Cited by 21
Chen, Y., Tang, D., Wu, H., Wu, Y., Yuan, T., Zhang, H., Jiao, Y., Yu, W., & Yan, H. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03050-y · Cited by 20
Yu, L. C., Li, H., Zhang, C., Zhang, Q., Guo, J., Li, J., Yuan, H., Li, L., Carmichael, P. L., & Peng, S. (2019) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2019.103296 · Cited by 21
Zhang, C., Zhang, Q., Li, J., Yu, L. C., Li, F., Li, W., Li, Y., Peng, H., Zhao, J. Y., Carmichael, P. L., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104661 · Cited by 20
Innovation for hepatotoxicity in vitro research models: A review
Han, W., Wu, Q., Zhang, X., & Duan, Z. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3711 · Cited by 23
Vilas‐Boas, V., Gijbels, E., Leroy, K., Pieters, A., Baze, A., Parmentier, C., & Vinken, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011005 · Cited by 18
Garzel, B., Zhang, L., Huang, S. M., & Wang, H. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666190709170256 · Cited by 24
Gelatin-Based Hybrid Hydrogel Scaffolds: Toward Physicochemical Liver Mimicry
Carpentier, N., der Meeren, L. V., Skirtach, A. G., Devisscher, L., Vlierberghe, H. V., Dubruel, P., & Vlierberghe, S. V. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00643 · Cited by 19
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency
Li, C. Z., Ogawa, H., Ng, S. S., Chen, X., Kishimoto, E., Sakabe, K., Fukami, A., Hu, Y., Mayhew, C. N., Hellmann, J., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100446 · Cited by 19
Gijbels, E., Devisscher, L., & Vinken, M. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112165 · Cited by 18
Notenboom, S., Weigand, K. M., Proost, J. H., van Lipzig, M. M. H., van de Steeg, E., van den Broek, P. H. H., Greupink, R., Rüssel, F. G. M., & Groothuis, G. M. M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.01.007 · Cited by 15
Liu, J., Li, R., Zhang, T., Xue, R., Li, T., Li, Z., Zhuang, X., Wang, Q., Chen, Y.-A., Dong, J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05042-x · Cited by 17
Messner, C. J., Mauch, L., & Suter‐Dick, L. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.06.002 · Cited by 15
Ingelman-Sundberg, M., & Lauschke, V. M. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0096 · Cited by 14
Self-citationEvaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes
Fardel, O., Moreau, A., Vée, M. L., Denizot, C., & Parmentier, Y. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0502-x · Cited by 15
Primary hepatocyte cultures for liver disease modeling
Vinken, M. (2020) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2020.08.003 · Cited by 14
Predicting drug-induced cholestasis: preclinical models
Petrov, P., Fernández-Murga, M. L., López-Riera, M., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1487399 · Cited by 14
Cholangiocyte organoids to study drug-induced injury
Wang, Z., Xing, C., van der Laan, L. J. W., Verstegen, M. M. A., Spee, B., & Masereeuw, R. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03692-6 · Cited by 13
Around 90° Contact Angle of Dish Surface Is a Key Factor in Achieving Spontaneous Spheroid Formation
Li, X., Li, N., Chen, K., Nagasawa, S., Yoshizawa, M., & Kagami, H. (2018) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0188 · Cited by 13
Nautiyal, M., Qasem, R. J., Fallon, J. K., Wolf, K., Liu, J., Dixon, D., Smith, P. C., & Mosedale, M. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.105010 · Cited by 14
Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis
Karsten, R. E. H., Krijnen, N., Maho, W., Permentier, H. P., Verpoorte, E. M. J., & Olinga, P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03321-2 · Cited by 11
Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety
Jadalannagari, S., & Ewart, L. C. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2328794 · Cited by 15
Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI
Stern, S., Wang, H., & Sadrieh, N. K. (2023) · Cells · doi:10.3390/cells12111476 · Cited by 14
Ex Vivo Model in Cholestasis Research
Karsten, R. E. H., Oosterhuis, D., van Wijk, L. A., & Olinga, P. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_23 · Cited by 9
Drug-induced cholestasis assay in primary hepatocytes
Brantegem, P. V., Chatterjee, S., Bruyn, T. D., Annaert, P., & Deferm, N. (2020) · MethodsX · doi:10.1016/j.mex.2020.101080 · Cited by 13
Exosomal microRNAs Release as a Sensitive Marker for Drug-Induced Liver Injury In Vitro
Messner, C. J., Premand, C., Gaiser, C., Kluser, T., Kübler, E., & Suter‐Dick, L. (2020) · Applied In Vitro Toxicology · doi:10.1089/aivt.2020.0008 · Cited by 10
Farzaneh, Z., Khojastehpour, F., Keivan, M., & Farzaneh, M. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220614160957 · Cited by 9
From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease
Kunst, R. F., Niemeijer, M., van der Laan, L. J. W., Spee, B., & van de Graaf, S. F. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114173 · Cited by 9
Waddington, J. C., Ali, S.-E., Penman, S. L., Whitaker, P., Hamlett, J., Chadwick, A. E., Naisbitt, D. J., Park, B. K., & Meng, X. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00400 · Cited by 10
Niu, X., Lin, M., & Lee, B. H. (2022) · Gels · doi:10.3390/gels8070404 · Cited by 10
Metadata
- Authors
- Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M.
- Affiliations
- Karolinska Institutet (SE)
- Venue
- Scientific Reports
- Published
- 2016-10-19
- Volume
- 6
- Issue
- 1
- Pages
- 35434-35434
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5069690
- OpenAlex
- W2539243243
- Cited by
- 156
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 10 · 2022: 17 · 2021: 18 · 2020: 26 · 2019: 23 · 2018: 18 · 2017: 10
- FWCI
- 21.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Commission (115336, 267038)
- Vetenskapsrådet (FP7/2007-2013)
- Staatssekretariat für Bildung, Forschung und Innovation
- Eurostars
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- drug-induced cholestasis, primary human hepatocytes, HepaRG cells, bile salt export pump, bile acids, synergistic toxicity, chlorpromazine, hepatotoxicity, ABCB11, F-actin cytoskeleton, oxidative stress, death receptor signaling
- MeSH terms
- Bile Acids and Salts, Biological Transport, Cell Line, Chlorpromazine, Cholestasis, Humans, Signal Transduction, Oxidative Stress, Spheroids, Cellular, Cell Culture Techniques, Hepatocytes, Receptors, TNF-Related Apoptosis-Inducing Ligand, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.